HIGHLIGHTS
- who: Nicolai Franzmeier from the Institute for Stroke and Dementia Research (ISD), University Hospital, Ludwig Maximilian University (LMU), Munich, Germany have published the research work: Higher CSF sTREM2 attenuates ApoE4-related risk for cognitive decline and neurodegeneration, in the Journal: (JOURNAL)
- what: The aim of this study was to assess whether higher sTREM2 attenuates the effects of ApoE4-effects on future cognitive decline and neurodegeneration. The absence of groupspecific (i.e. CN, MCI, AD dementia) sTREM2 increases in this study is potentially driven by the study design including subjects with mixed levels of both A . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.